Virbac SA (EPA:VIRP)
France · Delayed Price · Currency is EUR 352.00
-0.50 (-0.14%)
Feb 5, 2026, 11:42 AM CET
Virbac Market Cap
Virbac has a market cap or net worth of €2.95 billion as of February 5, 2026. Its market cap has increased by 11.59% in one year.
Market Cap
2.95B
Enterprise Value
3.14B
Revenue
1.43B
Ranking
n/a
PE Ratio
22.20
Stock Price
€352.00
Market Cap Chart
Since August 8, 1994, Virbac's market cap has increased from 217.52M to 2.95B, an increase of 1,257.66%. That is a compound annual growth rate of 8.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 2.95B | -1.40% |
| Dec 31, 2025 | 3.00B | 13.00% |
| Dec 31, 2024 | 2.65B | -12.68% |
| Dec 29, 2023 | 3.04B | 57.52% |
| Dec 30, 2022 | 1.93B | -46.24% |
| Dec 31, 2021 | 3.58B | 78.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 118.53B |
| Sanofi | 98.01B |
| Sartorius Stedim Biotech | 18.68B |
| Eurofins Scientific SE | 11.99B |
| ABIVAX Société Anonyme | 7.51B |
| emeis Société anonyme | 2.25B |
| Clariane SE | 1.37B |
| DBV Technologies | 1.16B |